Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Correction: A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.

Kasper KJ, Manoharan I, Hallam B, Coleman CE, Koivu SL, Weir MA, Delport J, McCormick JK, Silverman MS.

PLoS One. 2019 Sep 19;14(9):e0223079. doi: 10.1371/journal.pone.0223079. eCollection 2019.

2.

Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study.

Fleet JL, McArthur E, Patel A, Weir MA, Montero-Odasso M, Garg AX.

CMAJ. 2019 Sep 16;191(37):E1018-E1024. doi: 10.1503/cmaj.190337.

3.

The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.

Molnar AO, Petrcich W, Weir MA, Garg AX, Walsh M, Sood MM.

Nephrol Dial Transplant. 2019 Sep 8. pii: gfz167. doi: 10.1093/ndt/gfz167. [Epub ahead of print]

PMID:
31495887
4.

A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.

Kasper KJ, Manoharan I, Hallam B, Coleman CE, Koivu SL, Weir MA, McCormick JK, Silverman MS.

PLoS One. 2019 Aug 9;14(8):e0219777. doi: 10.1371/journal.pone.0219777. eCollection 2019. Erratum in: PLoS One. 2019 Sep 19;14(9):e0223079.

5.

Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study.

Nash DM, Markle-Reid M, Brimble KS, McArthur E, Roshanov PS, Fink JC, Weir MA, Garg AX.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1145-1154. doi: 10.1093/ndt/gfz062.

PMID:
31264694
6.

The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis.

Weir MA, Slater J, Jandoc R, Koivu S, Garg AX, Silverman M.

CMAJ. 2019 Jan 28;191(4):E93-E99. doi: 10.1503/cmaj.180694.

7.

Clinical Outcomes of Failing to Dose-Reduce Cephalosporin Antibiotics in Older Adults with CKD.

Bathini L, Jandoc R, Kuwornu P, McArthur E, Weir MA, Sood MM, Battistella M, Muanda FT, Liu A, Jain AK, Garg AX.

Clin J Am Soc Nephrol. 2019 Jan 10. pii: CJN.10710918. doi: 10.2215/CJN.10710918. [Epub ahead of print]

PMID:
30630861
8.

Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.

Weir MA, Walsh M, Cuerden MS, Sontrop JM, Chambers LC, Garg AX.

Can J Kidney Health Dis. 2018 Dec 5;5:2054358118813088. doi: 10.1177/2054358118813088. eCollection 2018.

9.

Population-Based Study of Risk of AKI with Levetiracetam.

Yau K, Burneo JG, Jandoc R, McArthur E, Muanda FT, Parikh CR, Wald R, Weir MA, Garg AX.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):17-26. doi: 10.2215/CJN.07490618. Epub 2018 Dec 11.

PMID:
30538089
10.

Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial.

Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, Cuerden MS, Weir MA, Bagga A, Brimble S, Burke A, Muirhead N, Pandeya S, Garg AX.

JAMA. 2018 May 8;319(18):1870-1879. doi: 10.1001/jama.2018.4930.

11.

β-Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial.

Tieu A, Velenosi TJ, Kucey AS, Weir MA, Urquhart BL.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):604-611. doi: 10.2215/CJN.07470717. Epub 2018 Mar 8.

12.

Beta blockers in patients with end-stage renal disease-Evidence-based recommendations.

Weir MA, Herzog CA.

Semin Dial. 2018 May;31(3):219-225. doi: 10.1111/sdi.12691. Epub 2018 Feb 26. Review.

PMID:
29482260
13.

Validation of an Algorithm to Identify Infective Endocarditis in People Who Inject Drugs.

Ball LJ, Sherazi A, Laczko D, Gupta K, Koivu S, Weir MA, Mele T, Tirona R, McCormick JK, Silverman M.

Med Care. 2018 Oct;56(10):e70-e75. doi: 10.1097/MLR.0000000000000838.

PMID:
29200131
14.

Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis.

Tan VS, Nash DM, McArthur E, Jain AK, Garg AX, Juurlink DN, Weir MA.

Can J Cardiol. 2017 Nov;33(11):1498-1504. doi: 10.1016/j.cjca.2017.09.003. Epub 2017 Sep 12.

PMID:
29111110
15.

The Chronic Kidney Disease Water Intake Trial: Protocol of a Randomized Controlled Trial.

Clark WF, Huang SH, Garg AX, Gallo K, House AA, Moist L, Weir MA, Sontrop JM.

Can J Kidney Health Dis. 2017 Aug 22;4:2054358117725106. doi: 10.1177/2054358117725106. eCollection 2017.

16.

Advances in the management of hyperkalemia in chronic kidney disease.

Cowan AC, Gharib EG, Weir MA.

Curr Opin Nephrol Hypertens. 2017 May;26(3):235-239. doi: 10.1097/MNH.0000000000000320. Review.

PMID:
28212180
17.

Antiepileptic drugs and hyponatremia in older adults: Two population-based cohort studies.

Gandhi S, McArthur E, Mamdani MM, Hackam DG, McLachlan RS, Weir MA, Burneo JG, Garg AX.

Epilepsia. 2016 Dec;57(12):2067-2079. doi: 10.1111/epi.13593. Epub 2016 Nov 29.

18.

Second-Generation Antidepressants and Hyponatremia Risk: A Population-Based Cohort Study of Older Adults.

Gandhi S, Shariff SZ, Al-Jaishi A, Reiss JP, Mamdani MM, Hackam DG, Li L, McArthur E, Weir MA, Garg AX.

Am J Kidney Dis. 2017 Jan;69(1):87-96. doi: 10.1053/j.ajkd.2016.08.020. Epub 2016 Oct 20.

PMID:
27773479
19.

Risk of Ventricular Arrhythmia with Citalopram and Escitalopram: A Population-Based Study.

Qirjazi E, McArthur E, Nash DM, Dixon SN, Weir MA, Vasudev A, Jandoc R, Gula LJ, Oliver MJ, Wald R, Garg AX.

PLoS One. 2016 Aug 11;11(8):e0160768. doi: 10.1371/journal.pone.0160768. eCollection 2016.

20.

Atypical antipsychotic medications and hyponatremia in older adults: a population-based cohort study.

Gandhi S, McArthur E, Reiss JP, Mamdani MM, Hackam DG, Weir MA, Garg AX.

Can J Kidney Health Dis. 2016 Apr 11;3:21. doi: 10.1186/s40697-016-0111-z. eCollection 2016.

21.

Clearance of cardiovascular medications during hemodialysis.

Tieu A, Leither M, Urquhart BL, Weir MA.

Curr Opin Nephrol Hypertens. 2016 May;25(3):257-67. doi: 10.1097/MNH.0000000000000216. Review.

PMID:
27023840
22.

Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.

Hosseini-Moghaddam SM, Alhomayeed B, Soliman N, Weir MA, House AA.

Transpl Infect Dis. 2016 Jun;18(3):423-30. doi: 10.1111/tid.12533. Epub 2016 May 23.

PMID:
27016725
23.

Statin Safety in Chinese: A Population-Based Study of Older Adults.

Li DQ, Kim RB, McArthur E, Fleet JL, Hegele RA, Shah BR, Weir MA, Molnar AO, Dixon S, Tu JV, Anand S, Garg AX.

PLoS One. 2016 Mar 8;11(3):e0150990. doi: 10.1371/journal.pone.0150990. eCollection 2016.

24.

Consecutive first-morning urine samples to measure change in the albumin-to-creatinine ratio: a pilot study of a home urine collection protocol.

Sontrop JM, Garg AX, Li L, Gallo K, Schumann V, Winick-Ng J, Clark WF, Weir MA.

Can J Kidney Health Dis. 2016 Feb 1;3:3. doi: 10.1186/s40697-016-0095-8. eCollection 2016.

25.

Increased Risk of Adverse Renal Outcome Following Polyethylene Glycol Bowel Preparation Compared to Sodium Picosulfate.

Liu AR, Garg AX, Liu K, Shariff SZ, Jain AK, Weir MA.

J Clin Pharmacol. 2016 Aug;56(8):983-7. doi: 10.1002/jcph.688. Epub 2016 Jan 27. No abstract available.

PMID:
26634805
26.

Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.

Weir MA, Fleet JL, Dixon SN, Jain AK, Oliver M, Wald R, McIntyre C, Garg AX.

Blood Purif. 2015;40(3):232-42. doi: 10.1159/000438821. Epub 2015 Sep 18.

PMID:
26382240
27.

Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury.

Wald R, Adhikari NK, Smith OM, Weir MA, Pope K, Cohen A, Thorpe K, McIntyre L, Lamontagne F, Soth M, Herridge M, Lapinsky S, Clark E, Garg AX, Hiremath S, Klein D, Mazer CD, Richardson RM, Wilcox ME, Friedrich JO, Burns KE, Bagshaw SM; Canadian Critical Care Trials Group.

Kidney Int. 2015 Oct;88(4):897-904. doi: 10.1038/ki.2015.184. Epub 2015 Jul 8.

PMID:
26154928
28.

Cardiac, renal, and central nervous system dysfunction with eosinophilia: eosinophilic granulomatosis with polyangiitis.

Hemmett J, Qirjazi E, Weir MA, Moussa M, Landry YD, Gunaratnam L.

Lancet. 2015 Jan 31;385(9966):480. doi: 10.1016/S0140-6736(14)62352-7. No abstract available.

PMID:
25706976
29.

β-Blocker dialyzability and mortality in older patients receiving hemodialysis.

Weir MA, Dixon SN, Fleet JL, Roberts MA, Hackam DG, Oliver MJ, Suri RS, Quinn RR, Ozair S, Beyea MM, Kitchlu A, Garg AX.

J Am Soc Nephrol. 2015 Apr;26(4):987-96. doi: 10.1681/ASN.2014040324. Epub 2014 Oct 30.

30.

Surrogate outcomes for ESRD risk: the case for a 30% reduction in estimated GFR over 2 years.

Sontrop JM, Weir MA, Garg AX.

Am J Kidney Dis. 2014 Dec;64(6):845-7. doi: 10.1053/j.ajkd.2014.08.009. Epub 2014 Sep 4. No abstract available.

PMID:
25195156
31.

Altered mental status in older adults with histamine2-receptor antagonists: a population-based study.

Tawadrous D, Dixon S, Shariff SZ, Fleet J, Gandhi S, Jain AK, Weir MA, Gomes T, Garg AX.

Eur J Intern Med. 2014 Oct;25(8):701-9. doi: 10.1016/j.ejim.2014.06.021. Epub 2014 Jul 16.

PMID:
25044092
32.

Kidney function and population-based outcomes of initiating oral atenolol versus metoprolol tartrate in older adults.

Fleet JL, Weir MA, McArthur E, Ozair S, Devereaux PJ, Roberts MA, Jain AK, Garg AX.

Am J Kidney Dis. 2014 Dec;64(6):883-91. doi: 10.1053/j.ajkd.2014.06.009. Epub 2014 Jul 16.

PMID:
25037562
33.

Higher anti-depressant dose and major adverse outcomes in moderate chronic kidney disease: a retrospective population-based study.

Dev V, Dixon SN, Fleet JL, Gandhi S, Gomes T, Harel Z, Jain AK, Shariff SZ, Tawadrous D, Weir MA, Garg AX.

BMC Nephrol. 2014 May 10;15:79. doi: 10.1186/1471-2369-15-79.

34.

Hyponatremia and sodium picosulfate bowel preparations in older adults.

Weir MA, Fleet JL, Vinden C, Shariff SZ, Liu K, Song H, Jain AK, Gandhi S, Clark WF, Garg AX.

Am J Gastroenterol. 2014 May;109(5):686-94. doi: 10.1038/ajg.2014.20. Epub 2014 Mar 4.

PMID:
24589671
35.

The chronic kidney disease Water Intake Trial (WIT): results from the pilot randomised controlled trial.

Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, Weir MA, Garg AX.

BMJ Open. 2013 Dec 20;3(12):e003666. doi: 10.1136/bmjopen-2013-003666.

36.

Standard versus accelerated initiation of renal replacement therapy in acute kidney injury (STARRT-AKI): study protocol for a randomized controlled trial.

Smith OM, Wald R, Adhikari NK, Pope K, Weir MA, Bagshaw SM; Canadian Critical Care Trials Group.

Trials. 2013 Oct 5;14:320. doi: 10.1186/1745-6215-14-320.

37.

Retrieving clinical evidence: a comparison of PubMed and Google Scholar for quick clinical searches.

Shariff SZ, Bejaimal SA, Sontrop JM, Iansavichus AV, Haynes RB, Weir MA, Garg AX.

J Med Internet Res. 2013 Aug 15;15(8):e164. doi: 10.2196/jmir.2624.

38.

Risk of acute kidney injury from oral acyclovir: a population-based study.

Lam NN, Weir MA, Yao Z, Blake PG, Beyea MM, Gomes T, Gandhi S, Mamdani M, Wald R, Parikh CR, Hackam DG, Garg AX.

Am J Kidney Dis. 2013 May;61(5):723-9. doi: 10.1053/j.ajkd.2012.12.008. Epub 2013 Jan 10.

PMID:
23312723
39.

Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes.

Gandhi S, Shariff SZ, Beyea MM, Weir MA, Hands T, Kearns G, Garg AX.

BMJ Open. 2013 Jan 3;3(1). pii: e001921. doi: 10.1136/bmjopen-2012-001921.

40.

Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission.

Fleet JL, Shariff SZ, Gandhi S, Weir MA, Jain AK, Garg AX.

BMJ Open. 2012 Dec 28;2(6). pii: e002011. doi: 10.1136/bmjopen-2012-002011. Print 2012.

41.

Validity of the International Classification of Diseases 10th revision code for hospitalisation with hyponatraemia in elderly patients.

Gandhi S, Shariff SZ, Fleet JL, Weir MA, Jain AK, Garg AX.

BMJ Open. 2012 Dec 28;2(6). pii: e001727. doi: 10.1136/bmjopen-2012-001727. Print 2012.

42.

Availability of renal literature in six bibliographic databases.

Shariff SZ, Sontrop JM, Iansavichus AV, Haynes RB, Weir MA, Gandhi S, Cuerden MS, Garg AX.

Clin Kidney J. 2012 Dec;5(6):610-617. Epub 2012 Nov 11.

43.

Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents.

Weir MA, Gomes T, Winquist E, Juurlink DN, Cuerden MS, Mamdani M.

J Oncol Pract. 2012 May;8(3):179-83. doi: 10.1200/JOP.2011.000287. Epub 2012 Jan 17.

44.

Oral bisphosphonate use in the elderly is not associated with acute kidney injury.

Shih AW, Weir MA, Clemens KK, Yao Z, Gomes T, Mamdani MM, Juurlink DN, Hird A, Hodsman A, Parikh CR, Wald R, Cadarette SM, Garg AX.

Kidney Int. 2012 Oct;82(8):903-8. doi: 10.1038/ki.2012.227. Epub 2012 Jun 13.

45.

New fibrate use and acute renal outcomes in elderly adults: a population-based study.

Zhao YY, Weir MA, Manno M, Cordy P, Gomes T, Hackam DG, Juurlink DN, Mamdani M, Moist L, Parikh CR, Paterson JM, Wald R, Yao Z, Garg AX.

Ann Intern Med. 2012 Apr 17;156(8):560-9. doi: 10.7326/0003-4819-156-8-201204170-00003.

PMID:
22508733
46.

Does orlistat cause acute kidney injury?

Beyea MM, Garg AX, Weir MA.

Ther Adv Drug Saf. 2012 Apr;3(2):53-7. doi: 10.1177/2042098611429985. Review.

47.

Impact of PubMed search filters on the retrieval of evidence by physicians.

Shariff SZ, Sontrop JM, Haynes RB, Iansavichus AV, McKibbon KA, Wilczynski NL, Weir MA, Speechley MR, Thind A, Garg AX.

CMAJ. 2012 Feb 21;184(3):E184-90. doi: 10.1503/cmaj.101661. Epub 2012 Jan 16. Erratum in: CMAJ. 2012 Sep 4;184(12):1394.

48.

Sulodexide for diabetic nephropathy: another one bites the dust.

House AA, Weir MA.

Am J Kidney Dis. 2011 Nov;58(5):692-4. doi: 10.1053/j.ajkd.2011.08.011. No abstract available.

PMID:
22014634
49.

Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.

Antoniou T, Gomes T, Mamdani MM, Yao Z, Hellings C, Garg AX, Weir MA, Juurlink DN.

BMJ. 2011 Sep 12;343:d5228. doi: 10.1136/bmj.d5228.

50.

Orlistat and acute kidney injury: an analysis of 953 patients.

Weir MA, Beyea MM, Gomes T, Juurlink DN, Mamdani M, Blake PG, Wald R, Garg AX.

Arch Intern Med. 2011 Apr 11;171(7):703-4. doi: 10.1001/archinternmed.2011.103. No abstract available.

PMID:
21482850

Supplemental Content

Support Center